-SEC Filing
Stifel Initiates Coverage On IDEAYA Biosciences with Hold Rating, Announces Price Target of $27
Stifel analyst Benjamin Burnett initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Hold rating and announces Price Target of $27.